Robert J Schulz
Overview
Explore the profile of Robert J Schulz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
23
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsuboi I, Matsukawa A, Kardoust Parizi M, Schulz R, Mancon S, Fazekas T, et al.
Clin Genitourin Cancer
. 2025 Feb;
23(2):102306.
PMID: 39952876
Despite currently used intravesical therapies in non-muscle-invasive bladder cancer (NMIBC), the rate of intravesical recurrence remains very high. We aimed to evaluate the effectiveness of adding nonintravesical interventions to standard...
2.
Tsuboi I, Schulz R, Laukhtina E, Wada K, Karakiewicz P, Araki M, et al.
Eur Urol Open Sci
. 2025 Feb;
73:31-42.
PMID: 39935942
Background And Objective: In patients with prostate cancer treated with antiandrogen monotherapy, gynecomastia and breast pain are relatively common. In the setting of androgen receptor pathway inhibitors (ARPIs), the incidence...
3.
Matsukawa A, Litterio G, Cormio A, Miszczyk M, Kardoust Parizi M, Fazekas T, et al.
Cancers (Basel)
. 2025 Jan;
17(2).
PMID: 39857987
: The addition of androgen receptor pathway inhibitors (ARPIs) to androgen deprivation therapy (ADT), with or without docetaxel (Doc), is currently recommended for metastatic, hormone-sensitive prostate cancer (mHSPC). Recently, the...
4.
Matsukawa A, Yanagisawa T, Miszczyk M, Kardoust Parizi M, Fazekas T, Tsuboi I, et al.
Eur Urol Focus
. 2025 Jan;
PMID: 39848859
Background And Objective: There is an established association between secondary bladder cancers (SBCs) and radiotherapy (RT) for prostate cancer (PC), which remains a significant concern. Our aim was to update...
5.
Schulz R, Ofner H, Nyirady P, Rajwa P, Weiss J, Shariat S, et al.
Curr Opin Urol
. 2025 Jan;
35(2):148-156.
PMID: 39744760
Purpose Of Review: Men face distinctive health-related challenges as a result of biological, behavioral, and sociocultural factors. In addition, the modern healthcare system does not offer men equal opportunities and...
6.
Tsuboi I, Matsukawa A, Kardoust Parizi M, Miszczyk M, Fazekas T, Schulz R, et al.
Clin Genitourin Cancer
. 2024 Nov;
22(6):102237.
PMID: 39546952
Although immune checkpoint inhibitors (ICI) and/or tyrosine kinase inhibitors (TKI) are the standard treatment of advanced unresectable or metastatic renal cell carcinoma (RCC), the impact of concomitant medications remains unclear....
7.
Tsuboi I, Rajwa P, Campi R, Miszczyk M, Fazekas T, Matsukawa A, et al.
Eur Urol Oncol
. 2024 Oct;
PMID: 39455341
Background And Objective: While active surveillance (AS) is an alternative to surgical interventions in patients with small renal masses (SRMs), evidence regarding its oncological efficacy is still debated. We aimed...
8.
Tsuboi I, Kardoust Parizi M, Matsukawa A, Mancon S, Miszczyk M, Schulz R, et al.
Urol Oncol
. 2024 Oct;
PMID: 39379210
Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with a high recurrence rate after surgical therapy with curative intent. Adjuvant radiotherapy (RT) and mitotane therapy have been proposed as...
9.
Tsuboi I, Matsukawa A, Kardoust Parizi M, Klemm J, Schulz R, Cadenar A, et al.
World J Urol
. 2024 Aug;
42(1):488.
PMID: 39162743
Context: Radical nephroureterectomy (RNU) with bladder cuff resection is the standard treatment in patients with high-risk upper tract urothelial cancer (UTUC). However, it is unclear which specific surgical technique may...
10.
Klemm J, Dahlem R, Schulz R, Stelzl D, Filipas D, Brommer C, et al.
J Urol
. 2024 Aug;
212(5):738-748.
PMID: 39092698
Purpose: There is a paucity of long-term objective and patient-reported outcomes after definitive perineal urethrostomy for complex urethral strictures. Our objective is to determine comprehensive long-term success of perineal urethrostomy...